Los Angeles – – September 30, 2026 -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) has signed a non-binding term sheet to move its entire EAI robotics business into Nasdaq-listed AIxCrypto Holdings, Inc. (NASDAQ: AIXC), at a proposed valuation of approximately $200 million in an all-stock deal.
Jinan – – September 30, 2026 -- Niutech Technology Group Co., Ltd. (SSE STAR Market: 688309) completed a group restructuring on August 26, 2026, consolidating nearly 40 years of industrial continuous pyrolysis operations as tightening EU recycling rules drive new orders for its waste tire and plastics processing lines.
A UK customer assessed Niutech's European and Chinese project references, benchmarked the company against competitors worldwide, and signed an order worth RMB 198 million for chemical recycling equipment. The company frames the deal as capital-backed validation of its technology maturity in international waste plastic recycling.
Los Angeles – September 30, 2026 -- The California Consortium of Addiction Programs and Professionals (CCAPP) will run its 13th Annual California Addiction Conference (CAC) from October 14-18, 2026, at the Sheraton Universal Hotel in Universal City, consolidating three previously separate summits into a single five-day program.
Washington – September 30, 2026 -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reported positive topline results from a pivotal Phase III study of HETLIOZ® (tasimelteon) 20 mg in adults with Delayed Sleep-Wake Phase Disorder (DSWPD), setting up a supplemental New Drug Application (sNDA) filing with the U.S. Food and Drug Administration (FDA).
The study, VP-VEC-162-3502 (NCT04652882), shifted sleep onset 42.5 minutes earlier in the HETLIOZ® arm (n=20) versus 5.4 minutes on placebo (n=20), a 37.1-minute difference (p=0.022). In an exploratory responder analysis, 60% of tasimelteon-treated participants (12/20) advanced sleep onset by at least 30 minutes, compared with 15% on placebo (3/20) (p=0.008).
Indianapolis – September 30, 2026 -- Eli Lilly and Company (NYSE: LLY) reported that its investigational triple hormone receptor agonist retatrutide produced an average weight loss of 49.6 lbs (20.8%) over 80 weeks at the 12 mg dose in patients with type 2 diabetes and obesity, with more than half of participants no longer meeting BMI criteria for obesity. The Phase 3 TRIUMPH-2 results were presented at the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan and simultaneously published in The Lancet.
Across the three tested doses, participants lost an average of 29.8 lbs (12.7%) at 4 mg, 45.4 lbs (19.1%) at 9 mg, and 49.6 lbs (20.8%) at 12 mg. Among patients with a baseline BMI of 35 or higher, the 12 mg dose produced an average loss of 60.8 lbs (23.4%), with 59.5% of all 12 mg participants no longer classified as having obesity by trial end.
Phnom Penh – September 30, 2026 -- Cambodia, Indonesia, the Philippines, and Thailand are shipping raw critical minerals abroad while processing and value capture happen elsewhere, according to a new report from Fair Finance Asia (FFA) and research partner Profundo.
The report, titled Extraction to Equity, examined critical minerals trade agreements and memoranda of understanding (MoUs) across the four ASEAN states using public data through December 2025. It found that local-benefits clauses, sustainability standards, and equitable value-sharing provisions were consistently missing, leaving source countries without leverage to demand better terms.
Washington – – September 30, 2026 -- Fannie Mae has completed the sale of its twenty-eighth Community Impact Pool (CIP) of non-performing loans, with VRMTG ACQ, LLC emerging as the winning bidder for a package of 24 loans carrying $6,200,360 in unpaid principal balance.
The single pool, geographically concentrated in the Dallas-Fort Worth area, was originally announced on September 30, 2026, and is scheduled to close on September 30, 2026. The average loan size in the pool stood at $258,348, with a weighted average note rate of 4.26% and a weighted average broker's price opinion loan-to-value ratio of 59%. The cover bid -- the second-highest offer received -- came in at 94.0740% of UPB, equivalent to 55.22% of BPO value.
Woburn, Mass. – – September 30, 2026 -- Cytrellis Biosystems, Inc. has signed a commercialization agreement with KoreAx Co. Ltd. to launch its ellacor skin-removal device in South Korea, marking the company's second international market entry of 2026 after Australia.
Ellacor is described as the first and only FDA-cleared, minimally invasive, in-office procedure that removes sagging skin without surgery or thermal energy. The device uses Micro-Coring technology and is approved for adults aged 22 and older with Fitzpatrick skin types I-IV.
The Bronx, N.Y. – September 30, 2026 -- The International Organization for Standardization published the third revision of ISO 3941 on September 30, 2026, introducing Class L as a distinct fire classification for lithium-ion cell and battery fires, arriving as New York City enforces a 1 kWh threshold for lithium-ion energy storage systems under its amended NFPA 855 code. Allstate Sprinkler, a Bronx-based fire protection contractor operating since 1972, released an analysis linking the new global standard to New York's existing regulatory posture and to FDNY incident data spanning 2023 through mid-2026.
New York – September 30, 2026 -- MyComplianceOffice (MCO), a compliance management software provider for financial services, has appointed John Schobel as President, adding a 25-year RegTech veteran to lead its global go-to-market strategy following a $100 million-plus strategic financing round.
The compliance software firm now serves more than 1,500 client companies across over 125 countries, onboarding more than 100 new firms during the same period. The growth trajectory coincides with recent strategic growth financing from Accel-KKR Credit Partners, which MCO says will fund continued expansion and product development.